Aβ-polyacrolein aggregates: Novel mechanism of plastic formation in senile plaques

Biochemical and Biophysical Research Communications

Volumn 335, Issue 2, 2005, Pages 501-504

  Seidler, Norbert W ^a   Squire, Trevor J ^a  

^a KANSAS CITY UNIVERSITY OF MEDICINE AND BIOSCIENCES   (United States)

Author keywords

Acrolein; Alzheimer's disease; Amyloid ; Light microscopy; Polyacrolein

Indexed keywords

AMYLOID BETA PROTEIN; ACROLEIN; AMYLOID; BIOPOLYMER; PEPTIDE; PEPTIDE FRAGMENT; PLASTIC; POLYACROLEIN; POLYMER;

ALZHEIMER DISEASE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; SENILE PLAQUE; BIOPHYSICS; BRAIN; CHEMISTRY; METABOLISM; METHODOLOGY; TIME;

ACROLEIN; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN; BIOPHYSICS; BIOPOLYMERS; BRAIN; HUMANS; PEPTIDE FRAGMENTS; PEPTIDES; PLASTICS; POLYMERS; SENILE PLAQUES; TIME FACTORS;

EID: 23744513820     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.07.111     Document Type: Article

References (24)

1. D.A. Butterfield, A. Castegna, C.M. Lauderback, and J. Drake Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death Neurobiol. Aging 23 2002 655 664
2. M.A. Lovell, C. Xie, and W.R. Markesbery Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures Neurobiol. Aging 22 2001 187 194
3. N.Y. Calingasan, K. Uchida, and G.E. Gibson Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease J. Neurochem. 72 1999 751 756
4. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128
5. K. Uchida Role of reactive aldehyde in cardiovascular diseases Free Radic. Biol. Med. 28 2000 1685 1696
6. J.L. Southwell, G.S. Yeargans, C. Kowalewski, and N.W. Seidler Acrolein modifies and inhibits cytosolic aspartate aminotransferase J. Enzyme Inhib. Med. Chem. 17 2002 19 23
7. N.W. Seidler, and G.S. Yeargans Albumin-bound polyacrolein: implications for Alzheimer's disease Biochem. Biophys. Res. Commun. 320 2004 213 217
8. J.T. Jarrett, E.P. Berger, and P.T. Lansbury Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease Biochemistry 32 1993 4693 4697
9. W.P. Esler, E.R. Stimson, J.M. Jennings, H.V. Vinters, J.R. Ghilardi, J.P. Lee, P.W. Mantyh, and J.E. Maggio Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism Biochemistry 39 2000 6288 6295
10. A.J. Modler, K. Gast, G. Lutsch, and G. Damaschun Assembly of amyloid protofibrils via critical oligomers-a novel pathway of amyloid formation J. Mol. Biol. 325 2003 135 148
11. M.R. Nichols, M.A. Moss, D.K. Reed, W.L. Lin, R. Mukhopadhyay, J.H. Hoh, and T.L. Rosenberry Growth of beta-amyloid (1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy Biochemistry 41 2002 6115 6127
12. C. Schladitz, E.P. Vieira, H. Hermel, and H. Mohwald Amyloid-beta-sheet formation at the air-water interface Biophys. J. 77 1999 3305 3310
13. E. Maltseva, and G. Brezesinski Adsorption of amyloid beta (1-40) peptide to phosphatidylethanolamine monolayers Chem. phys. chem. 5 2004 1185 1190
14. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding Anal. Biochem. 72 1976 248 254
15. J. Dong, R.P. Apkarian, and D.G. Lynn Imaging amyloid beta peptide oligomeric particles in solution Bioorg. Med. Chem. 2005 [Epub ahead of print]
16. S.J. Wood, B. Maleeff, T. Hart, and R. Wetzel Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta J. Mol. Biol. 256 1996 870 877
17. K.C. Evans, E.P. Berger, C.G. Cho, K.H. Weisgraber, and P.T. Lansbury Jr. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease Proc. Natl. Acad. Sci. USA 92 1995 763 767
18. C.S. Goldsbury, S. Wirtz, S.A. Muller, S. Sunderji, P. Wicki, U. Aebi, and P. Frey Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors J. Struct. Biol. 130 2000 217 231
19. C. Li, J. Orbulescu, G. Sui, and R.M. Leblanc Amyloid-like formation by self-assembly of peptidolipids in two dimensions Langmuir 20 2004 8641 8645
20. M. Chang, G. Richards, and A. Rembaum Polyacrolein microspheres: preparation and characteristics Methods Enzymol. 112 1985 150 164
21. B. Soreghan, J. Kosmoski, and C. Glabe Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation J. Biol. Chem. 269 1994 28551 28554
22. K. Uchida, M. Kanematsu, K. Sakai, T. Matsuda, N. Hattori, Y. Mizuno, D. Suzuki, T. Miyata, N. Noguchi, E. Niki, and T. Osawa Protein-bound acrolein: potential markers for oxidative stress Proc. Natl. Acad. Sci. USA 95 1998 4882 4887
23. J.C. Gan, A. Oandasan, and G.A. Ansari In vitro covalent modification of serum albumin by acrolein Chemosphere 23 1991 939 947
24. M.D. Kaytor, and S.T. Warren Aberrant protein deposition and neurological disease J. Biol. Chem. 274 1999 37507 37510